Source: BioCentury

NovImmune: Sobi buying Novimmune assets as it refocuses R&D

Read full article »
NovImmune's Competitors | NovImmune's News | NovImmune's Financials
Stay up-to-date with the latest news on NovImmune
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Erik Trock Jansen's photo - CEO of NovImmune

CEO

Erik Trock Jansen

CEO Approval Rating

88/100

Read more
Stay up-to-date with the latest news on NovImmune